Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To validate the morphine-sparing effect and safety of parecoxib administered intravenously for the treatment of Chinese subjects with postoperative pain following gynecological or orthopedic surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Parecoxib and placebo | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| To validate the morphine-sparing effect of parecoxib administered intravenously for the treatment of Chinese subjects with postoperative pain following gynecological or orthopedic surgery. |
| Measure | Description | Time Frame |
|---|---|---|
| To validate safety of parecoxib administered intravenously for the treatment of Chinese subjects with postoperative pain following gynecological or orthopedic surgery. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Guangzhou | Guangdong | 510080 | China | ||
| Pfizer Investigational Site |
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| C409945 | parecoxib |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Shenyang |
| Liaoning |
| 110001 |
| China |
| Pfizer Investigational Site | Qingdao | Shandong | 266011 | China |
| Pfizer Investigational Site | Beijing | 100020 | China |
| Pfizer Investigational Site | Beijing | 100034 | China |
| Pfizer Investigational Site | Beijing | 100083 | China |
| Pfizer Investigational Site | Shanghai | 200025 | China |
| Pfizer Investigational Site | Shanghai | 200032 | China |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |